At a time when the Indian medical device industry is being hailed as a sunrise sector, with domestic manufacturers eyeing the US as a key market to fuel their growth, the recent announcement of a 26% tariff on Indian exports has caused a stir and stakeholders apprehend the risk of losing their cost-advantage and Investors interest.

 Besides this, reports from the ongoing bilateral trade negations between the two nations indicate India plans to lower duties and other non-tariff assistance on US exports has made the terrain more bumpy. Under such a challenging landscape, ETHealthworld is set to host a webinar featuring key Industry experts and market analysts to understand the implications of these developments and how Indian Device makers are planning to counter this effect and safeguard their interest

ET Healthworld